We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open3,270
High3,332
Low3,220
Prev. Close3,245.1
Avg. Traded Price3,292.35
Volume1,21,504

MARKET DEPTH

info2
Total bid0.00
Total ask97.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
3245.1297
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

3,220.005 hours ago
3,332.0010 hours ago
arrow

LOWER/UPPER CIRCUITS

2,616.90
3,925.30
arrow
Glaxosmithkline Pharmaceuticals Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 8.92%, in the last year to ₹3,895.14 Cr. Its sector's average revenue growth for the last fiscal year was 9.78%.
noteAnnual Net Profit,rose 56.12% in the last year to ₹927.58 Cr. Its sector's average net profit growth for the last fiscal year was 34.97%.
noteReturn on Equity(ROE),for the last financial year was 47.53%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 8.45%
Net profit growth 5Y CAGR : 5.78%
Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.
personal

Grow your wealth with more research recommendations

+91